Natera, Inc. has entered into a partnership agreement with BGI Genomics Co., Ltd. aimed at developing, manufacturing, and commercializing NGS-based genetic testing assays. This collaboration is set to enhance the capabilities of genetic testing for clinical and commercial use.
Company Information
Company
Natera
Location
13011 Mccallen Pass
Austin, Texas, United States
About
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.